Agios Pharmaceuticals Inc. (AGIO)
NASDAQ · Healthcare
Agios Pharmaceuticals Inc. Price to FCF Ratio 2013–2026
Price to free cash flow (P/FCF) ratio for Agios Pharmaceuticals Inc. (AGIO): market cap divided by trailing twelve-month free cash flow. As of September 30, 2017 it is 113.28.
From: 06/30/2013To: 03/31/2026
Stock Price
TTM Free Cash Flow
Price to FCF
Agios Pharmaceuticals Inc. Price to FCF Ratio — FAQ
Agios Pharmaceuticals Inc. (AGIO) price to fcf ratio over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AGIO's price to fcf ratio history?
The chart and table above show Agios Pharmaceuticals Inc.'s price to fcf ratio by year and by quarter, including the growth rate.